Call: (414) 763-6910    Fax: 414-763-6911
Call: (414) 763-6910    Fax: 414-763-6911
Location: 2675 N. Mayfair Rd. Suite 400, Milwaukee, WI 53226 Get Directions

As of spring 2019, we are the only provider in the state of Wisconsin that offers TMS for OCD that is FDA approved!

Background information on OCD

  • 1 of 40 people will suffer from OCD and nearly 1 in 10 from symptoms of OCD in their lifetime. (1)
  • 85% endure serious or moderate impairment/distress due to their symptoms (2)
  • It takes and average of 14-17 years from when OCD first appears for people to receive treatment (3)

Mainstays of OCD treatment

The mainstays of OCD treatment with strong empirical data supporting their effectiveness are pharmacotherapy, neuromodulatory techniques, and evidence-based psychotherapy (e.g. exposure therapy) However, many patients still continue to report insufficient relief.


  • Existing treatments have resulted in greater than or equal to 30% improvement in only about half of the patients. (4)
  • Pharmacotherapy also often presents side effects that can be difficult to tolerate.


  • It is an invaluable tool in OCD. However, OCD treatment is best optimized with a well-trained therapist and the therapy itself is often lengthy. It often works best in concert with other treatment modalities as opposed to monotherapy.
  • Other neuromodulatory techniques have been utilized in practice and these include deep brain stimulation as well as electroconvulsive therapy. However, expose patients to the risks of anesthesia and there is a smaller pool of candidates who are medically appropriate. In addition, deep brain stimulation is a surgical procedure although it can be quite effective in severe cases.

Transcranial Magnetic Stimulation (TMS)

  • This is an FDA approved non-medication-based adjunct for treating OCD. It generates a magnetic field that turns on and off quickly, generating an electric current. The electric current activates cells in the brain that tend to be under-active in psychiatric disorders and promotes release of neurotransmitters that help mood. TMS also utilizes a concept termed neuroplasticity. By stimulating the neurons, the brain can be induced to create new pathways for effective transmission.

  • This is a very well tolerated treatment modality with a very low drop out rate. (5)
  • Why deep TMS as opposed to other TMS facilities?

  • Deep TMS is uniquely offered through Brainsway in comparison to other figure of 8 coils in the Milwaukee area.
  • It is based on patents licensed from the National Institutes of Health (NIH), enabling non-invasive activation of deep brain structures that can address a wide range of neurosychiatric conditions
  • To date, this is the only FDA approved TMS device for the treatment of OCD
  • Greater than 1 in 3 treatment resistant patients achieved a response with deep TMS
  • Approximately half reported overall improvement

  • Deep TMS technology has also been utilized at various major academic centers including Duke University Medical Center, Johns Hopkins, McLean Hospital (a Harvard Medical School affiliate), and Columbia University Medical Center

  • Deep TMS technology also stimulates a broader area and produces a deeper effective electric field than figure of 8 coils. (6)

  • There are ongoing or completed trials regarding application of TMS technology to conditions such as schizophrenia, bipolar depression, PTSD, Alzheimer's disease, Parkinson's disease, multiple sclerosis, autism, smoking cessation, chronic pain, and stroke rehabilitation

Why New Frontiers TMS LLC?

  • Dr. Hong Yin is not only experienced at providing high quality TMS. She is a strong advocate of practicing evidence based (in other words, substantiated in the medical literature to be effective) treatments whether it is TMS or not. Numerous studies have demonstrated the efficacy of a multipronged approach as being superior to monotherapy/single modality therapy in various psychiatric conditions. The reason being is that how we feel is affected by a multitude of factors at play. To form an effective plan, we must have a good idea of what the underlying causes are. At New Frontiers TMS LLC, our aim is to get an accurate diagnostic picture and then cater your treatment/medical advice to your individual circumstances. These may often include evidence-based medication management (the right class, mechanism of action, duration of treatment, and dosage) as well as various psychotherapy modalities (e.g. dialectical behavioral therapy, cognitive behavioral therapy, exposure response prevention). She is interested in not only offering you treatment options that are helpful but in helping you formulate a plan to help you sustain the therapeutic benefits.
  • Accessibility: if you have limited insurance, no insurance, or are uncertain of your benefits, please do not hesitate to contact us at all. We would be more than happy to provide an initial phone conversation free of charge to discuss if potentially deep TMS could be of benefit in your case.

1. Harvard Medical School, 2007. National Comorbidity Survey (NCSSC). (2017, August 21). Retrieved from Data Table 1: Lifetime Prevalence DSM-IV/WMH-CIDI disorders by sex and cohort.

2. Harvard Medical School, 2007. National Comorbidity Survey (NCSSC). (2017, August 21). Retrieved from Data Table 2: 12-month prevalence of DSM-IV/WMH-CIDI disorders by sex and cohort.


4. McDougle CJ, Goodman WK, Leckman JF, Price LH. The psychopharmacology of obsessive-compulsive disorder implications for treatment and pathogenesis. PsychiatrClinNorth Am. 1993;16:749-766.

5. Final Physician Labeling (FDA De Novo No. DEN170078)

To begin your OCD treatment, call New Frontiers Psychiatric & TMS at 414-763-6910 or use our convenient Request an Appointment form. We welcome patients from Milwaukee, New Berlin, Waukesha, Wauwatosa, West Allis and nearby cities and towns.


2675 N. Mayfair Rd. Suite 400, Milwaukee WI 53226